Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World

Authors	SHAH Ravi GAYAT Etienne JANUZZI James L. SATO Naoki COHEN-SOLAL Alain DISOMMA Salvatore FAIRMAN Enrique HARJOLA Veli-Pekka ISHIHARA Shiro LASSUS Johan MAGGIONI Aldo METRA Marco MUELLER Christian MUELLER Thomas PAŘENICA Jiří PASCUAL-FIGAL Domingo PEACOCK Frank ŠPINAR Jindřich KIMMENADE Roland van MEBAZAA Alexandre
Year of publication	2014
Type	Article in Periodical
Magazine / Source	Journal of The American College of Cardiology
MU Faculty or unit	Faculty of Medicine
Citation
Doi	http://dx.doi.org/10.1016/j.jacc.2013.09.072
Field	Cardiovascular diseases incl. cardiosurgery
Keywords	heart failure; obesity; obesity paradox
Description	Objective To define the relationship between body mass index (BMI) and mortality in heart failure (HF) across the world and identify specific groups in whom BMI may differentially mediate risk. Background Obesity is associated with incident heart failure (HF), but is paradoxically associated with better prognosis during chronic HF. Methods We studied 6,142 patients with acute decompensated HF from 12 prospective observational cohorts followed across 4 continents. Primary outcome was all-cause mortality. Cox proportional hazards models and net reclassification index (NRI) described associations of BMI with all-cause mortality. Results “Normal” weight patients (BMI 18.5-25 kg/m2) were older with more advanced HF and lower cardiometabolic risk. Despite worldwide heterogeneity in clinical features across obesity categories, a higher BMI remained associated with decreased 30-day and 1-year mortality (11% decrease at 30 days; 9% decrease at 1 year per 5 kg/m2; P<0.05), after adjustment for clinical risk. BMI obtained at index admission provided effective 1-year risk reclassification beyond current markers of clinical risk (NRI 0.119, P <.001). Notably, the “protective” association of BMI with mortality was confined to those with older age (>75; HR=0.82, P=0.006), decreased cardiac function (ejection fraction < 50%; HR=0.85, P<.001), non-diabetics (HR=0.86, P<.001), and de novo HF (HR=0.89, P=0.004). Conclusions A lower BMI is associated with age, disease severity, and a higher risk of death in ADHF. The “obesity paradox” is confined to older individuals, decreased cardiac function, less cardiometabolic illness, and recent onset HF, suggesting that aging, HF severity/chronicity, and metabolism may explain the obesity paradox.